Stefan Jaroch studied chemistry at the University of Bonn and obtained his PhD from the Ludwig Maximilians-Universität, Munich, in 1993. After a postdoc at the University of California, Irvine, he joined Schering AG and worked as medicinal chemist from 1995-2000 in Berlin and from 2000-2001 at the US subsidiary Berlex Biosciences in Richmond, CA. From 2001-2007, he was director in the medicinal chemistry department in Berlin, and from 2007-2010 in the medicinal chemistry department of Bayer Schering Pharma in Wuppertal. In his 15 years of pharma research experience his main interests were in the areas of anti-inflammation and oncology research. He holds an honorary professorship at the chemistry department of the Philipps-Universität Marburg since 2008. Since 2010, he focuses on collaborations with partners from academia, pharma, biotech, and CROs. As Head of External Innovation Technologies he is responsible for partnering activities referring to early drug discovery assets, technologies, and services, also including open innovation approaches. As of April 2015 he also acts as Project Coordinator in IMI’s European Lead Factory.